Translating science into healthier living
Biosciences at the 麻豆影院 aim to understand processes underlying behavior, function, disease and health at the molecular, cellular and whole-systems levels to develop interventions that improve human health.
Search
Biosciences News
CUriosity: Why does playing in the dirt feel so good?
From his home garden, CU 麻豆影院鈥檚 Chris Lowry explains why humans get so much enjoyment out of sinking their hands into dirt鈥攊t may have something to do with the friendly microbes that live in the soil. Read more
The light or the content? What we know about screens and sleep disruption
There鈥檚 a lot of research out there on screen time and sleep鈥攔ead the consensus from 16 leading sleep experts, who have just published an exhaustive scientific review. Read more
Geologists, biologists unearth the atomic fingerprints of cancer
Earth scientists have long turned to minute differences in hydrogen atoms to explore the ancient history of our planet. A new study suggests that these same tiny atoms could one day lead to new ways to track the growth of cancer. Read more
Biosciences In-Depth Stories
CU 麻豆影院 commercialization drives $8 billion in impact nationwide
Activities led by Venture Partners at CU 麻豆影院, the university鈥檚 commercialization arm, generated an economic impact of $8 billion nationally and $5.2 billion in the state of Colorado over the last five years Read more
Sniffing out diseases in real time
Breathalyzer based on frequency comb spectroscopy quantum tech shows promise as a non-invasive diagnostic test for an array of diseases Read more
Prenatal pollution exposure may impact baby鈥檚 brain
When pregnant moms breathe dirty air, it may adversely impact their baby鈥檚 brain, CU 麻豆影院 research suggests Read more
Faculty Leaders
With over 650 faculty and students involved in interdisciplinary bioscience research, CU 麻豆影院 is home to a dynamic scientific ecosystem that is shaping tomorrow鈥檚 leaders.
Impacting Humanity
Biosciences is the single greatest contributor to commercialization activity at CU 麻豆影院. In the last two decades, at least 89 biotech startups have emerged with roots at CU.
Research Institutes
Researchers at CU 麻豆影院 are empowered to explore new areas of bioscience by leveraging resources and talents across the university鈥檚 dedicated institutes.
13
National Academy of Science members
89+
Biotech startups with roots at CU (past 20 years)
7
Distinguished Professors
8
听American Association for the Advancement of Science members
RNA & DNA Discoveries
Tom Cech discovered that RNA is not only a molecule that encodes information but also a catalyst. Cech鈥檚 discovery laid the foundations for advances in molecular genetics and a growing appreciation of the biological roles of RNA.听
Making Chemotherapy Safer
Marvin Caruthers co-founded Amgen in 1980 to apply his work with RNA synthesis, DNA synthesis and analogues. Today, Amgen鈥檚 therapies help prevent infections in patients undergoing chemotherapy.
Fighting Cancer
Tin Tin Su鈥檚 innovative work with fruit flies led to the patenting of a compound that keeps radiation-treated cancer cells from re-growing. Her startup, SuviCa, develops cancer therapeutics that exploit a cellular mechanism critical to cancer re-growth after treatment with standard therapies.
Preventing Cardiovascular Disease
Doug Seals founded the Clinical Translational Research Center in 1999 to establish lifestyle and pharmacological strategies to extend 鈥渉ealthspan,鈥� the period of healthy life. Now, Seals鈥� research focuses on slowing and preventing cardiovascular disease.
Leading in the Classroom
Leslie Leinwand is renowned for her study of the molecules involved in muscle contraction and heart disease. Her research opens the door to the possibility of personalized heart-disease treatment. Committed to teaching and training, Leinwand is a national influencer in shaping biomedical research policies.
Developing Treatments for Infectious Disease
Biologist Larry Gold, an internationally regarded DNA and RNA researcher, co-founded Synergen in 1981, when biotechnology was still an emerging field. In 1992, he founded NeXagen, now part of Gilead Sciences, which develops treatments for infectious disease. And in 2000, he founded SomaLogic with the goal of transforming how diseases are detected and diagnosed.
Pain Management
Linda Watkins strives to understand how to control pathological pain states. Her work has yielded 300-plus peer-reviewed publications in journals such as Nature, Science and Journal of听Neuroscience. A co-founder of Xalud Therapeutics, she is a world-renowned authority on the听neurological applications of glial attenuation, focusing on alleviating chronic pain.